Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer
patients with lymph node metastasis should receive after neoadjuvant chemotherapy. For …

Simple Summary The 5-year survival rate for patients with breast cancer, in whom disease
has spread to local lymph nodes, is 85%. However, many live with the complications of …

Background Targeted axillary dissection (TAD), the combination of sentinel lymph node
biopsy (SLNB) and targeted lymph node biopsy (TLNB), can reduce the false negative rates …

Purpose In clinically node-positive breast cancer, axillary staging after neoadjuvant
chemotherapy (NAC) is optimized with targeted axillary dissection (TAD), which includes …

Background Historically, axillary clearance with axillary lymph node dissection (ALND) was
important for the regional control of breast cancer. However, with increasing rates of early …

Background: In clinically node-positive (cN+) breast cancer (BC) patients who become
clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph …

Simple Summary Neoadjuvant therapy, which reduces advanced breast tumours before
surgery, is common in medical practice. However, accurately mapping lymph nodes post …

Simple Summary Marking impalpable areas of breast cancer prior to surgery is an important
part of the modern treatment of breast cancer. Traditionally, the target lesion would be …

BACKGROUND: This is a prospective, single-institution study to evaluate feasibility and
accuracy of radar-localized reflector (RLR)–targeted axillary dissection (TAD) in node …

Selective sentinel lymph node biopsy (SNLB) is the standard method for detecting regional
metastases in breast cancer patients. Identifying affected axillary lymph nodes before …